| CAS NO: | 1952272-74-0 |
| 包装 | 价格(元) |
| 1mg | 电议 |
| 5mg | 电议 |
| 10mg | 电议 |
| 生物活性 | Bemarituzumab is a first-in-class, humanizedIgG1monoclonal antibody againstFGFR2b(a FGF receptor). Bemarituzumab blocks fibroblast growth factors from binding and activating FGFR2b. Bemarituzumab has the potential forcancerresearch[1]. |
| Clinical Trial | |
| 性状 | Liquid |
| CAS 号 | 1952272-74-0 |
| 中文名称 | 贝玛妥珠单抗 |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
m.cnreagent.com